Foreign Drug Makers Face Novartis-Type Deals To Enter China's Market
This article was originally published in PharmAsia News
Executive Summary
Foreign drug makers hoping to take advantage of China's large market may have to swallow lower profit margins, just as Novartis has, former health Minister Chen Zhu said in an interview.